For clear single‐gene diseases and breast cancer caused by certain highly epigenetic susceptibility genes, such as the BRCA1 pathogenic variant, genetic blockade of the corresponding diseases can be achieved by PGT‐M [48]. This evidence concerns the gene BRCA1 and breast carcinoma.